From: Progress and controversies in developing cancer vaccines
Characteristic | Detail | Advantage vs | |
---|---|---|---|
 |  | Tumor cell antigen sources | adoptive cellular therapy |
Pure | Avoid tolerizing cellular antigens; exclude normal protein, avoid autoimmunity. | X | Â |
Processed | Avoid effects of immunoproteasome | X | Â |
Cheap | Feasible to study without corporate support | X | X |
Easier | Lower regulatory hurdles | X | X |
Evaluable | Excellent cancer vaccine model, allowing direct evaluation of response to the specific immunogen | X | Â |
Modifiable | Create synthetic peptides better than native peptides | X | Â |
Immunogenic | Induce T cell responses in patients | Â | Â |
Combinable | Multipeptide vaccines may mimic immune effects of whole cell vaccines. | Â | Â |